Is a complete BCBA/LLY research report available?

No complete published report is available for bcba/LLY (BCBA/LLY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bcba/LLY stock profile: metrics, valuation and analysis

Market cap	1503.2T
Revenue (ttm)	118T
Net income (ttm)	39.6T
EPS (ttm)	ARS 44,133
P/E (trailing)	38.0x
P/E (forward)	28.3x
Dividend	ARS 124 (0.39%)
Volume	13,963
Beta	0.50

All BCBA/LLY indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	50,000
Employees Change	3,000%
Employees Change Percent	6.38
Enterprise value	ARS 1571.4T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-09-12
Market cap	ARS 1503.2T
Price	ARS 31,880
Price currency	ARS
Rev Per Employee	2,360,503,580x
Sector	Healthcare
Sic	2834
Symbol	bcba/LLY
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.63%
EV Earnings	39.71x
EV/EBIT	26.25x
EV/EBITDA	24.8x
EV/FCF	58.31x
EV/Sales	13.05x
FCF yield	1.79%
Forward P/E	28.26x
P/B ratio	29.95x
P/E ratio	37.99x
P/S ratio	12.74x
PE Ratio10 Y	52.78x
PE Ratio3 Y	71.41x
PE Ratio5 Y	62.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	49.72%
EBITDA Margin	52.35%
FCF margin	22.41%
Gross margin	83.4%
Gross Profit	ARS 98.4T
Gross Profit Growth	50.96%
Gross Profit Growth Q	50.31%
Gross Profit Growth3 Y	42.51%
Gross Profit Growth5 Y	26.7%
Net Income	ARS 39.6T
Net Income Growth	93.56%
Net Income Growth Q	25.33%
Net Income Growth Qo Q	-4.07%
Net Income Growth3 Y	60.19%
Net Income Growth5 Y	34.49%
Pretax Margin	42.17%
Profit Margin	33.53%
Profit Per Employee	ARS 791.4M
ROA	20.36
Roa5y	13.51
ROCE	41.89
ROE	102.3
Roe5y	74.21
ROIC	42.24
Roic5y	35.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	65.68%
Cagr3y	60.53%
Cagr5y	110.5%
Div CAGR10	83.01%
Div CAGR3	125.8%
Div CAGR5	107.18%
EPS Growth	94.8
EPS Growth Q	26.23
EPS Growth Qo Q	-3.87
EPS Growth3 Y	60.68
EPS Growth5 Y	34.97
FCF Growth	272.37%
FCF Growth Q	458.06%
FCF Growth Qo Q	157.96%
FCF Growth3 Y	69.77%
FCF Growth5 Y	26.73%
OCF Growth	156.73%
OCF Growth Q	246.29%
OCF Growth Qo Q	100.45%
OCF Growth10 Y	23.94%
OCF Growth3 Y	65.09%
OCF Growth5 Y	31.67%
Revenue Growth	49.58x
Revenue Growth Q	47.67x
Revenue Growth Qo Q	16.04x
Revenue Growth3 Y	39.23x
Revenue Growth5 Y	24.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.66
Assets	ARS 210.8T
Cash	ARS 13.3T
Current Assets	ARS 97.6T
Current Liabilities	ARS 72.1T
Debt	ARS 81.3T
Debt EBITDA	ARS 1.31
Debt Equity	ARS 1.62
Debt FCF	ARS 3.02
Equity	ARS 50.2T
Interest Coverage	215.3
Liabilities	ARS 160.6T
Long Term Assets	ARS 113.2T
Long Term Liabilities	ARS 88.5T
Net Cash	ARS -66.9T
Net Cash By Market Cap	ARS -4.45
Net Debt EBITDA	ARS 1.08
Net Debt Equity	ARS 1.33
Net Debt FCF	ARS 2.48
Tangible Book Value	ARS 10.3T
Tangible Book Value Per Share	ARS 11,500
WACC	6.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.35
Inventory Turnover	0.95
Net Working Capital	ARS 22.3T
Quick ratio	0.68
Working Capital	ARS 25.1T
Working Capital Turnover	ARS 8,502

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend Growth	68.52%
Dividend Growth Years	23%
Dividend per share	ARS 124
Dividend Years	27
Dividend Yield	0.39%
Ex Div Date	2026-08-14
Last Dividend	ARS 46.09
Payout Frequency	Quarterly
Payout Ratio	21.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	65.63%
200-day SMA	28,981.9
3Y total return	313.82%
50-day SMA	33,502.4
50-day SMA vs 200-day SMA	50over200
5Y total return	4,031.05%
All Time High	36,520
All Time High Change	-12.71%
All Time High Date	2026-08-19
All Time Low	328.6
All Time Low Change	9,602.62%
All Time Low Date	2020-11-03
ATR	969.2
Beta	0.5
Ch YTD	8.51
High	32,320
High52	36,520
High52 Date	2026-08-19
High52ch	-12.71%
Low	31,840
Low52	17,720
Low52 Date	2025-09-25
Low52ch	79.91%
Ma50ch	-4.84%
Price vs 200-day SMA	10%
RSI	39.85
RSI Monthly	67.25
RSI Weekly	54.14
Sharpe ratio	1.5x
Sharpe Ratio3y	1.37x
Sharpe Ratio5y	1.77x
Sortino ratio	2.58
Sortino Ratio3y	2.19
Sortino Ratio5y	2.89
Total Return	1.01%
Tr YTD	8.88
Tr1m	-8.16%
Tr1w	-1.85%
Tr3m	3.98%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	888,950,429%
Net Borrowing	22,966,125,124,080
Shares Insiders	0.17%
Shares Institutions	89.5%
Shares Qo Q	-0.25%
Shares Yo Y	-0.62%
Short Ratio	2.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 26T
Adjusted OCF	40,643,471,000,000
Average Volume	12,607.45x
Bv Per Share	56,300.3
CAPEX	ARS -14.7T
Ch1m	-8.29
Ch1w	-1.85
Ch1y	64.93
Ch3m	3.84
Ch3y	309.1
Ch5y	3,952.3
Ch6m	22.05
Change	-0.69%
Change From Open	-1.18
Close	32,100
Days Gap	0.5
Depreciation Amortization	3,168,105,719,995
Dollar Volume	445,140,440
Earnings Date	2026-10-29
EBIT	ARS 58.7T
EBITDA	ARS 61.8T
EPS	ARS 44,133
F Score	7
FCF	ARS 26.9T
FCF EV Yield	1.71x
Financing CF	3,863,752,000,000
Fiscal Year End	December
Founded	1,876
Goodwill	13,356,154,128,745
Graham Number	4483.4703
Graham Upside	-85.94
Income Tax	ARS 10.2T
Investing CF	-37,181,205,500,000
Is Primary Listing	0
Last Earnings Date	2026-08-05
Last Report Date	2026-06-30
Last Split Date	2024-01-24
Last Split Type	Forward
Lynch Fair Value	ARS 20,982
Lynch Upside	-34.19
Ma150	29,101.5
Ma150ch	9.55%
Ma20	33,640
Ma20ch	-5.23%
Net CF	8,257,881,000,000
Next Earnings Date	2026-10-29
Open	32,260
P FCF Ratio	55.78
P FCF Ratio SBC	57.84
P OCF Ratio	36.13
P OCF Ratio SBC	36.98
Payment Date	2026-09-10
Position In Range	8.33
Ppne	44,202,546,029,430
Price Date	2026-09-11
Price EBITDA	ARS 24.33
Ptbv Ratio	146.6
Relative Volume	1.13x
Revenue	118,025,179,000,000x
SBC By Revenue	0.81x
Share Based Comp	961,493,500,000
Tax By Revenue	8.64x
Tax Rate	20.49%
Tr6m	22.34%
Volume	13,963
Z Score	6.55

BCBA/LLY (BCBA/LLY)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/LLY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/LLY indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BCBA/LLY

Frequently asked questions